Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 13;13(12):e0209050.
doi: 10.1371/journal.pone.0209050. eCollection 2018.

Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2

Affiliations

Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2

Rie Matsushima-Nishiwaki et al. PLoS One. .

Abstract

A bioactive lipid, sphingosine 1-phosphate (S1P), acts extracellularly as a potent mediator, and is implicated in the progression of various cancers including hepatocellular carcinoma (HCC). S1P exerts its functions by binding to five types of specific receptors, S1P receptor 1 (S1PR1), S1PR2, S1PR3, S1PR4 and S1PR5 on the plasma membrane. However, the exact roles of S1P and each S1PR in HCC cells remain to be clarified. In the present study, we investigated the effect of S1P on the hepatocyte growth factor (HGF)-induced migration of human HCC-derived HuH7 cells, and the involvement of each S1PR. S1P dose-dependently reduced the HGF-induced migration of HuH7 cells. We found that all S1PRs exist in the HuH7 cells. Among each selective agonist for five S1PRs, CYM5520, a selective S1PR2 agonist, significantly suppressed the HGF-induced HuH7 cell migration whereas selective agonists for S1PR1, S1PR3, S1PR4 or S1PR5 failed to affect the migration. The reduction of the HGF-induced migration by S1P was markedly reversed by treatment of JTE013, a selective antagonist for S1PR2, and S1PR2- siRNA. These results strongly suggest that S1P reduces the HGF-induced HCC cell migration via S1PR2. Our findings may provide a novel potential of S1PR2 to therapeutic strategy for metastasis of HCC.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Effects of HGF on the phosphorylation of p38 MAPK and MYPT-1 in HuH7 cells.
The cultured cells were stimulated with 30 ng/ml HGF for the indicated periods. The cell extracts were then subjected to SDS-PAGE with subsequent Western blot analysis using antibodies against phospho-specific p38 MAPK, phospho-specific MYPT-1 or GAPDH.
Fig 2
Fig 2
Effects of SB203580, SP600125, PD98059, deguelin or Y27632 on the HGF-induced migration, and phosphorylation of p38 MAPK (A), JNK (B), ERK (C), AKT (D) and MYPT-1 (E) in HuH7 cells. For the cell migration, the cells were pretreated with the indicated doses of SB203580 (A), SP600125 (B), PD98059 (C), deguelin (D) or Y27632 (E) for 60 min, and then stimulated by 30 ng/ml of HGF or vehicle for 23 h. The migrated cells were fixed with paraformaldehyde, and stained with DAPI for nucleus (blue signal). The cells were photographed by fluorescent microscopy at a magnification of 20× (upper panel) and counted (bar graph). For the Western blot analysis, the cells were pretreated with the indicated doses of SB203580 (A), SP600125 (B), PD98059 (C), deguelin (D) or Y27632 (E) for 60 min, and then stimulated by 30 ng/ml of HGF or vehicle for 5 min ((A), (B) and (E)) or 3 min ((C) and (D)). Each value represents the mean ± SD of triplicate determinations from three independent cell preparations. * p<0.05 compared to the value of the control cells without HGF. **p<0.05 compared to the value of the cells with HGF alone. N.S. designates no significant difference between the indicated pairs. Scale bar: 100 μm.
Fig 3
Fig 3. Effect of S1P on the HGF-induced migration of HuH7 cells.
The cells were pretreated with the indicated doses of S1P for 60 min, and then stimulated by 30 ng/ml of HGF or vehicle for 23 h. The migrated cells were fixed with paraformaldehyde, and stained with DAPI for nucleus (blue signal). The cells were photographed by fluorescent microscopy at a magnification of 20× (upper panel) and counted (bar graph). Each value represents the mean ± SD of triplicate determinations from three independent cell preparations. *p<0.05 compared to the value of the control cells without HGF. **p<0.05 compared to the value of the cells with HGF alone. Scale bar: 100 μm.
Fig 4
Fig 4. S1PRs in HuH7 cells.
The HuH7 cell extract was subjected to SDS-PAGE with subsequent Western blot analysis using antibodies against S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 or GAPDH.
Fig 5
Fig 5. Effect of agonists of S1PR1-5 on the HGF-induced migration of HuH7 cells.
The cells were pretreated with the indicated doses of SEW2871 (A), CYM5520 (B), CYM5541 (C), CYM50260 (D) or A971432 (E) for 60 min, and then stimulated by 30 ng/ml of HGF or vehicle for 23 h. The migrated cells were fixed with paraformaldehyde, and stained with DAPI for nucleus (blue signal). The cells were photographed by fluorescent microscopy at a magnification of 20× (upper panel) and counted (bar panel). Each value represents the mean ± SD of triplicate determinations from three independent cell preparations. *p<0.05 compared to the value of the control cells without HGF. **p<0.05 compared to the value of the cells with HGF alone. N.S. designates no significant difference between the indicated pairs. Scale bar: 100 μm.
Fig 6
Fig 6. Effect of JTE013 on the suppression by S1P of the HGF-induced migration of HuH7 cells.
The cells were pretreated with 1 μM of JTE013 for 10 min prior to 10 μM of S1P treatment for 60 min, and then stimulated by 30 ng/ml of HGF or vehicle for 23 h. The migrated cells were fixed with paraformaldehyde, and stained with DAPI for nucleus (blue signal). The cells were photographed by fluorescent microscopy at a magnification of 20× (upper panel) and counted (bar panel). Each value represents the mean ± SD of triplicate determinations from three independent cell preparations. *p<0.05 compared to the value of the control cells without HGF. **p<0.05 compared to the value of the cells with HGF alone. ***p<0.05 compared to the value of the cells with HGF and S1P pretreatment. N.S. designates no significant difference between the indicated pairs. Scale bar: 100 μm.
Fig 7
Fig 7. Effect of S1PR2-siRNA on the suppression by S1P of HGF-induced migration of HuH7 cells.
The S1PR2-siRNA or negative control siRNA transfected HuH7 cells were pretreated with 10 μM of S1P for 60 min, and then stimulated by 30 ng/ml of HGF or vehicle for 23 h. The migrated cells were fixed with paraformaldehyde, and stained with DAPI for nucleus (blue signal). The cells were photographed by fluorescent microscopy at a magnification of 20× (upper panel) and counted (bar panel). Each value represents the mean ± SD of triplicate determinations from three independent cell preparations. *p<0.05 compared to the value of the control cells without HGF. **p<0.05 compared to the value of the cells with HGF alone. N.S. designates no significant difference between the indicated pairs. Scale bar: 100 μm.
Fig 8
Fig 8. A schematic illustration of the regulatory mechanism of S1P in HGF-induced HCC cell migration.
S1P, sphingosine 1-phosphate; HGF, hepatocyte growth factor; HCC, hepatocellular carcinoma, S1PR, sphingosine 1-phosphate receptor.

Similar articles

Cited by

References

    1. Liovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016; 2: 1–23. - PubMed
    1. Natsuizaka M, Omura T, Akaike T, Kuwata Y, Yamazaki K, Sato T, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastasis. J Gastroenterol Hepatol. 2005; 20: 1781–1787. 10.1111/j.1440-1746.2005.03919.x - DOI - PubMed
    1. Sneag DB, Krajewski K, Giardino A, O’Regan KN, Shinagare AB, Jagannathan JP, et al. Extrahepatic spread or hepatocellular carcinoma: Spectrum of imaging findings. AJR Am J Roentgenol. 2011; 197: W658–W664. 10.2214/AJR.10.6402 - DOI - PubMed
    1. Poon RTP, Fan ST, Lo CM, Liu CL, Wong J. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation. Impact on long-term survival. Ann Surg. 2007; 245: 51–58. 10.1097/01.sla.0000225255.01668.65 - DOI - PMC - PubMed
    1. Toso C, Mentha G, Majno P. Liver transplantation for hepatocellular carcinoma: Five steps to prevent recurrence. Am J Transplant. 2011; 11: 2031–2035. 10.1111/j.1600-6143.2011.03689.x - DOI - PubMed

Publication types

MeSH terms